performed both with and without sample weights (target cluster size divided by the actual number enrolled in cluster) to account for under- and over-enrolment, and the results were compared. For samples with a rifampicin result from both Xpert MTB/RIF and
-Est. Drugs Susceptibility Testing Results The MDR/rifampicin-resistant TB (MDR/RR-TB), pre-XDR-TB, or XDR-TB status for the patients is shown in Table 2. Xpert MTB/RIF detected 41 RR-TB patients – 20 newly treated and 21 PTPs. The overall prevalence
MA Momeny 2011 Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens J Clin Microbiol
. 14. WHO ( 2011 ) Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System, Policy Statement (WHO/HTM/TB/2011 .4